Miromatrix Medical Inc. Stock-Based Compensation
Miromatrix Medical Inc. reported Stock-Based Compensation of $933.42 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2023-11-14
- Miromatrix Medical Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $322.81K, a 27.72% increase year-over-year.
- Miromatrix Medical Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $278.65K, a 4.60% increase year-over-year.
- Miromatrix Medical Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $331.96K, a 0.61% decline year-over-year.
- Miromatrix Medical Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $298.34K, a 25.43% increase year-over-year.
- Miromatrix Medical Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $1.15M, a 85.08% increase from fiscal 2021.
- Miromatrix Medical Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $622.16K, a 3.52% decline from fiscal 2020.
- Miromatrix Medical Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $644.85K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $322.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $601.46K derived: sum of 2 quarters · filed 2023-11-14 | $933.42K 10-Q · filed 2023-11-14 | $1.23M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $278.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $610.61K 10-Q · filed 2023-08-14 | $908.95K derived: sum of 3 quarters · filed 2023-08-14 | $1.16M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | $331.96K 10-Q · filed 2023-05-11 | $630.30K derived: sum of 2 quarters · filed 2023-05-11 | $883.06K derived: sum of 3 quarters · filed 2023-11-14 | $1.15M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | $298.34K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $551.10K derived: sum of 2 quarters · filed 2023-11-14 | $817.49K derived: sum of 3 quarters · filed 2023-11-14 | $1.15M 10-K · filed 2023-03-31 |
| 2022-09-30 | $252.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $519.15K derived: sum of 2 quarters · filed 2023-11-14 | $853.13K 10-Q · filed 2023-11-14 | $1.09M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $266.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $600.37K 10-Q · filed 2023-08-14 | $838.23K derived: sum of 3 quarters · filed 2023-08-14 | $983.20K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $333.98K 10-Q · filed 2023-05-11 | $571.84K derived: sum of 2 quarters · filed 2023-05-11 | $716.81K derived: sum of 3 quarters · filed 2023-05-11 | $822.69K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $237.86K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $382.83K derived: sum of 2 quarters · filed 2023-03-31 | $488.71K derived: sum of 3 quarters · filed 2023-03-31 | $622.16K 10-K · filed 2023-03-31 |
| 2021-09-30 | $144.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $250.85K derived: sum of 2 quarters · filed 2022-11-14 | $384.30K 10-Q · filed 2022-11-14 | $556.96K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $105.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $239.33K 10-Q · filed 2022-08-15 | $411.99K derived: sum of 3 quarters · filed 2022-08-15 | $569.39K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $133.45K 10-Q · filed 2022-05-16 | $306.11K derived: sum of 2 quarters · filed 2022-05-16 | $463.51K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $172.66K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $330.06K derived: sum of 2 quarters · filed 2022-03-30 | $644.85K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $157.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $472.19K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $314.80K 10-Q · filed 2021-08-12 |